Strategic Partners

For nearly 50 years, NFID has been an innovative thought leader tackling the challenges and minimizing the impact of infectious diseases on US public health. NFID has educated and engaged millions, from families with small children to experienced healthcare professionals to community leaders and policy makers.

The NFID Strategic Partners Program enables organizations to engage deeply and to join a pivotal group of leaders in the field of infectious diseases. Specifically, the program offers access, awareness, and advancement. To learn more, view the program brochure.

2022 Strategic Partners

Platinum:
AstraZeneca
Janssen Therapeutics
ModernaTX, Inc.
Novavax, Inc.
Ocugen
Pfizer Inc.
Valneva USA, Inc.

Gold:
GSK
Merck & Co., Inc.
Sanofi Pasteur

Silver:
Bavarian Nordic
Takeda Pharmaceuticals USA, Inc.
VBI Vaccines Inc.